ScreenerHero

VENI Vencanna Ventures Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · vencanna.com
0.0050CAD0.00%Mkt Cap: 810717 $P/E: —

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is a venture capital firm specializing in seed/startups and early venture. It prefers to invest in cannabis sectors. The firm prefers to invest in com…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap810.72K USD
Enterprise Value-814.77K USD
Revenue (TTM)1.37M USD
Gross Profit-227.36K USD
Net Income (TTM)-960.55K USD
Revenue/Share0.0080 CAD
Last Price0.0050 CAD
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA92260V1031
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.82
EV/Revenue-0.59
P/S0.59
P/B0.32
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.00500% of range0.0100
52W High0.0100 CAD
52W Low0.0050 CAD
Profitability
Gross Margin-16.60%
Oper. Margin-25.62%
EBITDA Margin-72.18%
Profit Margin-70.15%
ROE-55.32%
ROA-68.58%
Growth
Revenue Growth-22.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-263.12K USD
CapEx (TTM)54.86K USD
FCF Margin-28.58%
FCF Yield-48.27%
Net Debt-25.53K USD
Net Debt/EBITDA0.03
Balance Sheet
Debt/Equity0.00
Current Ratio0.50
Quick Ratio0.25
Book Value/Sh0.02 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 7, 2010
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.222.64M
Float173.51M
Insiders19.05%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short530
Short (prev mo.)479
Technical
SMA 500.0050 (-0.0%)
SMA 2000.0051 (-2.0%)
Beta0.88
S&P 52W Chg16.45%
Avg Vol (30d)3.10K
Avg Vol (10d)2.70K
Technical Indicators
RSI (14)42.6
MACD-0.0001
MACD Signal-0.0002
MACD Hist.+0.0000
BB Upper0.0050 CAD
BB Middle0.0050 CAD
BB Lower0.0050 CAD
BB Width0.00%
ATR (14)0.0001 CAD
Vol Ratio (20d)0.00x